Zynex Inc. ZYXI recently announced the Food and Drug Administration (“FDA”) clearance of its new TensWave device, which aligns perfectly with Zynex’s commitment to providing comprehensive pain ...

ENGLEWOOD, Colo., Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, ...

LONE TREE, Colo.--(BUSINESS WIRE)-- Zynex, Inc. (OTCBB: ZYXI), a provider of pain management systems and electrotherapy products for medical patients with functional disability, announced that it ...

Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release. The InWave medical device will be manufactured, ...

LONE TREE, Colo., Feb. 1, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

The lawsuit contends that Zynex engaged in a scheme to inflate its reported revenue by routinely sending patients more products, including electrodes, than were medically necessary. This practice, the ...

Zynex Inc's (NASDAQ:ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, ...